Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease - PubMed (original) (raw)
Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease
Dimitrios Kapogiannis et al. FASEB J. 2015 Feb.
Abstract
Insulin resistance causes diminished glucose uptake in similar regions of the brain in Alzheimer's disease (AD) and type 2 diabetes mellitus (DM2). Brain tissue studies suggested that insulin resistance is caused by low insulin receptor signaling attributable to its abnormal association with more phospho (P)-serine-type 1 insulin receptor substrate (IRS-1) and less P-tyrosine-IRS-1. Plasma exosomes enriched for neural sources by immunoabsorption were obtained once from 26 patients with AD, 20 patients with DM2, 16 patients with frontotemporal dementia (FTD), and matched case control subjects. At 2 time points, they were obtained from 22 others when cognitively normal and 1 to 10 yr later when diagnosed with AD. Mean exosomal levels of extracted P-serine 312-IRS-1 and P-pan-tyrosine-IRS-1 by ELISA and the ratio of P-serine 312-IRS-1 to P-pan-tyrosine-IRS-1 (insulin resistance factor, R) for AD and DM2 and P-serine 312-IRS-1 and R for FTD were significantly different from those for case control subjects. The levels of R for AD were significantly higher than those for DM2 or FTD. Stepwise discriminant modeling showed correct classification of 100% of patients with AD, 97.5% of patients with DM2, and 84% of patients with FTD. In longitudinal studies of 22 patients with AD, exosomal levels of P-serine 312-IRS-1, P-pan-tyrosine-IRS-1, and R were significantly different 1 to 10 yr before and at the time of diagnosis compared with control subjects. Insulin resistance reflected in R values from this blood test is higher for patients with AD, DM2, and FTD than case control subjects; higher for patients with AD than patients with DM2 or FTD; and accurately predicts development of AD up to 10 yr prior to clinical onset.
Keywords: dementia; insulin resistance; senescence.
© FASEB.
Figures
Figure 1.
Cross-sectional analysis of altered levels of phosphorylated IRS-1 in AD, DM2, and FTD. AU, absorbance units at 450 nm; insulin resistance index, ratio of P-serine 312-IRS-1 (P-S312-IRS-1)/P-pan-tyrosine-IRS-1 (P-panY-IRS-1) (R); horizontal line in each cluster of individual values is the mean level for that group.
Figure 2.
Longitudinal analysis of the development of altered levels of phosphorylated IRS-1 in AD. PC-AD, preclinical values 1 to 10 yr before diagnosis for patients with AD; control, values for cognitively normal healthy subjects matched by age and gender with each patient with AD at the time of diagnosis. P-S312-IRS-1, P-serine 312-IRS-1; P-panY-IRS-1, P-pan-tyrosine-IRS-1.
Similar articles
- Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.
Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller BL, Goetzl EJ. Fiandaca MS, et al. Alzheimers Dement. 2015 Jun;11(6):600-7.e1. doi: 10.1016/j.jalz.2014.06.008. Epub 2014 Aug 15. Alzheimers Dement. 2015. PMID: 25130657 Free PMC article. - Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease.
Mullins RJ, Mustapic M, Goetzl EJ, Kapogiannis D. Mullins RJ, et al. Hum Brain Mapp. 2017 Apr;38(4):1933-1940. doi: 10.1002/hbm.23494. Epub 2017 Jan 20. Hum Brain Mapp. 2017. PMID: 28105773 Free PMC article. - Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease.
Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D. Goetzl EJ, et al. Neurology. 2015 Jul 7;85(1):40-7. doi: 10.1212/WNL.0000000000001702. Epub 2015 Jun 10. Neurology. 2015. PMID: 26062630 Free PMC article. - An update on potential links between type 2 diabetes mellitus and Alzheimer's disease.
De Sousa RAL, Harmer AR, Freitas DA, Mendonça VA, Lacerda ACR, Leite HR. De Sousa RAL, et al. Mol Biol Rep. 2020 Aug;47(8):6347-6356. doi: 10.1007/s11033-020-05693-z. Epub 2020 Aug 1. Mol Biol Rep. 2020. PMID: 32740795 Review. - IRS-1 regulation in health and disease.
Schmitz-Peiffer C, Whitehead JP. Schmitz-Peiffer C, et al. IUBMB Life. 2003 Jul;55(7):367-74. doi: 10.1080/1521654031000138569. IUBMB Life. 2003. PMID: 14584587 Review.
Cited by
- HIV-Associated Neurocognitive Disorder (HAND) and Alzheimer's Disease Pathogenesis: Future Directions for Diagnosis and Treatment.
Mustafa M, Musselman D, Jayaweera D, da Fonseca Ferreira A, Marzouka G, Dong C. Mustafa M, et al. Int J Mol Sci. 2024 Oct 17;25(20):11170. doi: 10.3390/ijms252011170. Int J Mol Sci. 2024. PMID: 39456951 Free PMC article. Review. - Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and Prognostics.
Dhauria M, Mondal R, Deb S, Shome G, Chowdhury D, Sarkar S, Benito-León J. Dhauria M, et al. Int J Mol Sci. 2024 Oct 10;25(20):10911. doi: 10.3390/ijms252010911. Int J Mol Sci. 2024. PMID: 39456697 Free PMC article. Review. - Alzheimer's disease biomarkers and their current use in clinical research and practice.
Hunter TR, Santos LE, Tovar-Moll F, De Felice FG. Hunter TR, et al. Mol Psychiatry. 2024 Sep 4. doi: 10.1038/s41380-024-02709-z. Online ahead of print. Mol Psychiatry. 2024. PMID: 39232196 Review. - Effects of chronic treatment with metformin on brain glucose hypometabolism and central insulin actions in transgenic mice with tauopathy.
Hurtado-Carneiro V, LeBaut-Ayuso Y, Velázquez E, Flores-Lamas C, Fernández-de la Rosa R, García-García L, Gómez-Oliver F, Ruiz-Albusac JM, Pozo MÁ. Hurtado-Carneiro V, et al. Heliyon. 2024 Aug 5;10(15):e35752. doi: 10.1016/j.heliyon.2024.e35752. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170185 Free PMC article. - Stress-Related Roles of Exosomes and Exosomal miRNAs in Common Neuropsychiatric Disorders.
Chamakioti M, Chrousos GP, Kassi E, Vlachakis D, Yapijakis C. Chamakioti M, et al. Int J Mol Sci. 2024 Jul 29;25(15):8256. doi: 10.3390/ijms25158256. Int J Mol Sci. 2024. PMID: 39125827 Free PMC article. Review.
References
- Cersosimo E., DeFronzo R. A. (2006) Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab. Res. Rev. 22, 423–436 - PubMed
- Sun X. J., Rothenberg P., Kahn C. R., Backer J. M., Araki E., Wilden P. A., Cahill D. A., Goldstein B. J., White M. F. (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73–77 - PubMed
- Yamada M., Ohnishi H., Sano Si., Nakatani A., Ikeuchi T., Hatanaka H. (1997) Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived neurotrophic factor in cultured cerebral cortical neurons. J. Biol. Chem. 272, 30334–30339 - PubMed
- Amoui M., Craddock B. P., Miller W. T. (2001) Differential phosphorylation of IRS-1 by insulin and insulin-like growth factor I receptors in Chinese hamster ovary cells. J. Endocrinol. 171, 153–162 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical